Table 3.
Age |
75-79 (N=310) |
80-84 (N=208) |
≥85 (N=163) |
p value* |
All cases (N=681) |
||||
---|---|---|---|---|---|---|---|---|---|
Treatments | 310 | % | 208 | % | 163 | % | 681 | % | |
No treatment |
|
|
|
|
|
|
0.006 |
|
|
Yes |
4 |
1.3 |
6 |
2.9 |
9 |
5.5 |
|
19 |
2.8 |
No |
304 |
98.1 |
197 |
94.7 |
145 |
89.0 |
|
646 |
94.9 |
Unknown |
2 |
0.6 |
5 |
2.4 |
9 |
5.5 |
|
16 |
2.3 |
Surgery alone |
|
|
|
|
|
|
0.02 |
|
|
Yes |
19 |
6.1 |
13 |
6.3 |
20 |
12.3 |
|
52 |
7.6 |
No |
272 |
87.7 |
184 |
88.5 |
126 |
77.3 |
|
582 |
85.5 |
Unknown |
19 |
6.1 |
11 |
5.3 |
17 |
10.4 |
|
634 |
93.1 |
Hormone therapy |
|
|
|
|
|
|
<0.001 |
|
|
Yes |
12 |
3.9 |
18 |
8.7 |
44 |
27.0 |
|
74 |
10.9 |
No |
277 |
89.4 |
176 |
84.6 |
93 |
57.1 |
|
546 |
80.2 |
Unknown |
21 |
6.8 |
14 |
6.7 |
26 |
16.0 |
|
61 |
9.0 |
Breast conserving surgery plus adjuvant therapy |
|
|
|
|
|
<0.001 |
|
|
|
Yes |
144 |
46.5 |
69 |
33.2 |
25 |
15.3 |
|
238 |
34.9 |
No |
157 |
50.6 |
135 |
64.9 |
132 |
81.0 |
|
424 |
62.3 |
Unknown |
9 |
2.9 |
4 |
1.9 |
6 |
3.7 |
|
19 |
2.8 |
Mastectomy plus adjuvant therapy |
|
|
|
|
|
|
0.40 |
|
|
Yes |
92 |
29.7 |
83 |
39.9 |
36 |
22.1 |
|
211 |
31.0 |
No |
208 |
67.1 |
116 |
55.8 |
116 |
71.2 |
|
440 |
64.6 |
Unknown |
10 |
3.2 |
9 |
4.3 |
11 |
6.7 |
|
30 |
4.4 |
Others† |
|
|
|
|
|
|
0.03 |
|
|
Yes |
18 |
5.8 |
5 |
2.4 |
3 |
1.8 |
|
26 |
3.8 |
No |
271 |
87.4 |
189 |
90.9 |
134 |
82.2 |
|
594 |
87.2 |
Unknown |
21 |
6.8 |
14 |
6.7 |
26 |
16.0 |
|
61 |
9.0 |
Abbreviations: N = number of patients.
*Cochran-Armitage trend test.
†Others: chemotherapy alone, radiotherapy alone, chemotherapy plus hormone therapy, chemotherapy plus radiotherapy, radiotherapy plus hormone therapy, chemotherapy plus radiotherapy plus hormone therapy, neoadjuvant chemotherapy plus surgery plus adjuvant therapy, neoadjuvant chemotherapy plus surgery.